Takeda Asks 1st Circ. Not To Revive Actos Kickback Suit
Counsel for Takeda Pharmaceuticals on Monday told a Fifth Circuit panel that 11 off-label prescriptions for its diabetes drug Actos written by unknown doctors to unknown patients and paid for by...To view the full article, register now.
Already a subscriber? Click here to view full article